As of 2024-12-11, the Fair Value of Heron Therapeutics Inc (HRTX) is -1.26 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.76 USD, the upside of Heron Therapeutics Inc is -171.39%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -204.70 | -227.30 | -220.70 | -182.00 | -110.56 | -189.05 |
| YoY growth | -14.49% | -11.04% | 2.90% | 17.54% | 39.25% | 6.83% |
| Market Cap (mil) | 267.68 |
| P/E | |
| Forward P/E |
| EPS | -0.18 |
| Avg earnings growth rate | 6.83% |
| TTM earnings | -27.97 |